Antivenom Neutralization of Coagulopathic Snake Venom Toxins Assessed by Bioactivity Profiling Using Nanofractionation Analytics
Venomous snakebite is one of the world’s most lethal neglected tropical diseases. Animal-derived antivenoms are the only standardized specific therapies currently available for treating snakebite envenoming, but due to venom variation, often this treatment is not effective in counteracting...
Main Authors: | Chunfang Xie, Julien Slagboom, Laura-Oana Albulescu, Ben Bruyneel, Kristina B. M. Still, Freek J. Vonk, Govert W. Somsen, Nicholas R. Casewell, Jeroen Kool |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Toxins |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6651/12/1/53 |
Similar Items
-
Neutralizing Effects of Small Molecule Inhibitors and Metal Chelators on Coagulopathic <i>Viperinae</i> Snake Venom Toxins
by: Chunfang Xie, et al.
Published: (2020-08-01) -
Varespladib Inhibits the Phospholipase A<sub>2</sub> and Coagulopathic Activities of Venom Components from Hemotoxic Snakes
by: Chunfang Xie, et al.
Published: (2020-06-01) -
High throughput screening and identification of coagulopathic snake venom proteins and peptides using nanofractionation and proteomics approaches.
by: Julien Slagboom, et al.
Published: (2020-04-01) -
Anticoagulant Activity of <i>Naja nigricollis</i> Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
by: Taline D. Kazandjian, et al.
Published: (2021-04-01) -
A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib
by: Arif Arrahman, et al.
Published: (2022-10-01)